FLT3 and leukemia: The effects of post-transplant sorafenib is multifaceted, including direct FLT mutation inhibition, GVL effect augmentation through IL-15 production in FLT3-ITD mutant leukemia cells, and also synergic effects with alloreactive T cells (110).